COSTESグループ

50
ICRR2015
50
70
5
36
2
(ICRR)
ICRR2015
50
ICRR2015
ICRR2015
50
ICRR2015
ICRR2015
JCO
4
Program-at-a-Glance
15:00
30
16:00
Day1 Monday, May 25
30
Plenary 1
Main Hall
Opening
Ceremony
Q
1-MH-P-01
Recent Progress in iPS
Cell Research and
Application
Shinya Yamanaka
Q
Kids' Japanese
Drum Performance
17:00
30
18:00
30
19:00
1-MH-P-02
The Accident of Fukushima
Japanese Art
Dai-ichi Nuclear Power
Station, Radiation and Future Performance
of Energy in the World
Welcome Reception
Q
Akito ArimaQ
13:00∼20:00
Registration
2DAY 2
A- SY1
RoomA
Session Number
30
Plenary 2
EO: Eye Opener
LS: Luncheon
SY: Symposium
P: Plenary
CL: Congress Lecture
PS: Poster Session
OS: Oral Session
20:00
Program-at-a-Glance
8:00
Room A
Biological Effects
30
Eye Opener
2-A-EO-01
Radiobiology of Normal Tissue
Effects in Radiation Oncology Progress and Perspectives
Wolfgang Doerr
(Austria)Q
Room B-1
Radiation Protection Sciences
9:00
30
Congress Lecture
2-A-CL-01
Charged Particles
Marco Durante
(Germany and Italy)
Award Lecture
The Bacq and Alexander
Award by ERRS
AW02-ERRS
Fukushima NPP Accident
Room B-2
Day2 Tuesday, May 26
Eye Opener
10:00
30
11:00
30
12:00
30
13:00
Luncheon Seminar1
Symposium
2-A-SY-01-01∼05
Tissue Stem Cells and
Radiation Carcinogenesis
Q
2-A-LS-1
Clinical Trial Using Anti-VEGF
Antibody with Chemoradiation for
Malignant Gliomas and the Role
of VEGF in Radiation Necrosis
Chugai Pharmaceutical Co., Ltd.
Symposium
2-B1-SY-09-01∼04
Environmental and Health Effect of
the Fukushima Nuclear Accident
Distribution, and Environmental Effect of Radioactive Materials
Q
Symposium
2-B2-EO-05
2-B2-SY-05-01∼06
Epidemiological Research on
Radiation-induced Cancer in
Atomic Bomb Survivors
Long-term Epidemiological Studies of
the A-bomb Survivors and Their Offspring:
Past, Present and Future
Q
Kotaro Ozasa
(Japan
Q
Eye Opener
Room C-1
Radiation Chemistry
Room C-2
Radiology, Nuclear Medicine
2-C1-EO-06
Symposium
Cutting Edge of Radiation
Chemistry: Game Changer
of Semiconductor
Manufacturing
2-C1-SY-06-01∼05
Radiation Chemistry and
Science in 21st Century
Q
Seiichi Tagawa
(Japan)Q
Eye Opener
2-C2-EO-08
Symposium
Tumor Hypoxia: A New
PET Imaging Marker
for Treatment Planning
2-C2-SY-08-01∼05
Molecular Imaging Using Radioisotope
in Clinical Oncology
Q
Nagara Tamaki
(Japan)Q
Eye Opener
Room D
Life Sciences
Room E
Non-ionizing Radiation
Environment Stressors
Annex 1
Radiation Oncology
Luncheon Seminar3
2-D-EO-03
Cloning of NBS1 and DNA
Repair Genes: Strand Break
Repair Is Linked to Cellular
DNA Damage Responses
JRRS Award
Lectures 2015
AW01-JRRS-01∼03
Kenshi Komatsu
(Japan)Q
Eye Opener
2-E-EO-04
Fumio Hanaoka
(Japan)Q
Eye Opener
Congress Lecture
High-throughput
Screens for Targets to
Modify Radiosensitivity
The Role of Dose Escalation Using
Hypofractionation, IMRT, and IGRT in
Patients with Locally Advanced
Pancreatic Cancer
W Gillies McKenna
(United Kingdom)
Q
2-D-SY-03-01∼04
Pathways and Players in DNA Repair
Q
Non-Ionizing Radiation and
Risk of Human Health: Comparison of
Ultraviolet Radiation and Ionizing Radiation
Q
Radiation Safety System for
a Particle Therapy Facility
Biology for Radiation Therapy
Event Hall
Robert Bristow
(Canada)Q
Poster Mounting
Hitachi Aloka Medical, Ltd.
2-AX1-LS-5
Symposium
2-AX1-SY-07-01∼05
Combination of Molecular Targetting Agents and Radiation
Q
High-dose-rate Brachytherapy
for Prostate Cancer
― An Approach to Extreme
Hypofractionation ―
Chiyoda Technol Corporation
Luncheon Seminar2
2-AX2-EO-02
Translating Tumour
Heterogeneity Analyses of
Hypoxia and Genomics to
Prostate Cancer Medicine
2-E-LS-4
Luncheon Seminar5
Eye Opener
Annex 2
Nihon Medi-Physics
Co., Ltd.
Luncheon Seminar4
2-AX1-CL-02
Christopher H Crane
(United States)Q
2-D-LS-3
Molecular Imaging
Theranostics
Symposium
2-E-SY-04-01∼04
Forty Years of DNA
Damage Tolerance
2-AX1-EO-07
Symposium
Symposium
2-AX2-SY-02-01∼05
Dose Rate Effect in Brachytherapy
Q
Poster Display
2-AX2-LS-2
Radiobiological Basis for Efficacy
of Cetuximab in Radiotherapeutic
Management of Head and Neck Cancer
Merck Serono Co., Ltd.
2-
A- SY1
DAY 2
13:00
RoomA
30
Session Number
14:00
30
EO: Eye Opener
OS: Oral Session
P: Plenary
SY: Symposium
LS: Luncheon
PS: Poster Session
CL: Congress Lecture
15:00
30
16:00
30
17:00
30
18:00
Congress Lecture
2-A-CL-03
The Response of The
Small Intestine To
Radiation Damage
Catherine Booth
(United Kingdom)
Q
Symposium
2-A-SY-10-01∼04
Radiation Response in Differentiated Cells
and Non-cancer Disease
Q
Oral Session01
2-A-OS-01-01∼05
Non-cancer Effects
Q
Symposium
2-B1-SY-18-01∼05
Environmental and Health Effect of
the Fukushima Nuclear Accident
Dose Estimation and Health Risk
Q
Congress Lecture
2-B2-CL-07
Dose Rate Effects in
Radiation Biology and
Radiation Protection
Werner Ruehm
(Germany)Q
Symposium
2-B2-SY-14-01∼05
New Aspects of Biological Responses to
Low-dose/Low-dose-rate Radiation
Q
Congress Lecture
2-C1-CL-08
Recent Progress in
Pulse Radiolysis
James F. Wishart
(United States)
Q
Symposium
Oral Session05
2-B2-OS-05-01∼04
Biological Effects as Bases
for Radiation Protection
Q
Oral Session06
2-C1-OS-06-01∼05
Pulse Radiolysis in 21st Century
Q
2-C1-SY-15-01∼05
Advanced Methods for
Basic and Applied
Radiation Research
Symposium
Oral Session08
Recent Advance in Targeted Radionuclide Therapy
Q
Nuclear Medicine & Radiology
Congress Lecture
2-C2-CL-10
Targeted Radionuclide Therapy-Recent
Advance and Information About The
Health Effect of Radioactive Materials
Released by The Nuclear AccidentKeigo Endo(Japan)
Q
2-C2-SY-17-01∼04
2-C2-OS-08-01∼05
Congress Lecture
2-D-CL-05
Tumour Suppressor
Mechanisms in The Control of
Genome Stability and
Radiation Responsiveness
Ashok Venkitaraman
(United Kingdom) Q Symposium
2-D-SY-12-01∼04
Oral Session03
2-D-OS-03-01∼05
Human Diversity Affecting Biological
Responses to Radiation
Q
DNA Damage Responses-1
Q
Symposium
Oral Session04
Genetic and Epigenetic Mechanism
of Environmental Stress
Q
Advances in Understanding
The Biological Consequence
by Environmental Stressors
Congress Lecture
2-E-CL-06
DNA Damage Repair
and The Impact on
Aging
Jan H.J. Hoeijmakers
(Netherlands)Q
2-E-SY-13-01∼04
2-E-OS-04-01∼04
Congress Lecture
2-AX1-CL-09
Recent Advances in
Radiation Therapy for
Head and Neck Cancer
Jean Bourhis
(Switzerland)Q
Congress Lecture
2-AX2-CL-04
Complexity of Micro-RNAs
in Human Cancers
Fei Fei Liu (Canada)
Q
Symposium
2-AX1-SY-16-01∼05
Radiation Oncology Update:
Breast Cancer
Q
Symposium
2-AX2-SY-11-01∼05
Predictive Assays for Radiotherapy:
Biomarkers for Strategies for Selection of RT
and/or RT Sensitive Phenotype
Q
Poster Display
Oral Session07
2-AX1-OS-07-01∼05
GI, GU, and Gyn
Oral Session02
2-AX2-OS-02-01∼05
Radiosensitivity-1
Poster Session 1
*Light meal is to be served
(sponsored)
Program-at-a-Glance
8:00
Room A
Biological Effects
Room B-1
Health Effects: A - Bombs
and Nuclear Accidents
30
9:00
30
10:00
30
11:00
Eye Opener
3-A-EO-09
Symposium
Low-dose Radiation Induces
Adaptive and Protective
Metabolic Response
3-A-SY-19-01∼04
Normal Tissue Response to Low-dose/
Low-dose-rate Irradiation
Q
Zhimin Yuan
(United States)Q
30
12:00
Award Lecture
L.H. Gray Medal
(Gray Award) by ICRU
AW03-ICRU
Fiona Stewart
(Netherlands)
30
13:00
Mechanisms of Development of
Cardiovascular Disease in Irradiated
Cancer Patients and The Possible
Influence of ErbB2 Blocking Agents
Eye Opener
3-B1-EO-15
Biological Dosimetry
in Large Scale
Accidents
Andrzej Wojcik
(Sweden)
Symposium
3-B1-SY-27-01∼05
Environmental and Health Effect of the Fukushima Nuclear Accident
Health Effect of Fukushima Nuclear Accident
Q
Room B-2
Radiation Protection Sciences
Day3 Wednesday, May 27
Luncheon Seminar8
Symposium
3-B2-SY-23-01∼08
DoReMi - Low Dose Research towards Multidisciplinary Integration - ICRR Symposia
Introduction to the European DoReMi Programme on Low Dose Risk Research
from DoReMi to CONCERT: Next Steps in European Radiation Protection Research
Q
ERRS YIA Session
AW04-ERRS
YIA-01∼08
3-B2-LS-8
Oncological Hyperthermia
at the Crossroad - Need
for Change of Paradigma
Tateyama Machine Co., Ltd.
Eye Opener
Room C-1
Radiation Chemistry
Room C-2
Radiology, Nuclear Medicine
Room D
Life Sciences
3-C1-EO-12
An Eye Opener on the Bright
Future of Radiation Chemistry and
Radiation Processing, and
Non-power Nuclear Applications
Mohamad I. AlSheikhly
(United States)Q
Symposium
3-C1-SY-24-01∼05
Innovative Processes and Materials Produced by Radiation
Q
Eye Opener
3-C2-EO-14
Symposium
Functional MR Imaging in
Gynecologic Field
3-C2-SY-26-01∼05
Radiation Dose Management on CT
Q
Kaori Togashi
(Japan)
Q
Health Effects of the Fukushima
Nuclear Accident and Research
on Low Dose Radiation
Eye Opener
3-D-EO-10
Symposium
Genetic Analysis of Proteins
Involved in The Initial Step of
Double-strand Break Repair
3-D-SY-21-01∼04
Dynamics of Chromatin and Nuclear Architecture
in Radiation Damaged Cells
Q
Shunichi Takeda
(Japan)Q
ICRR Special
Lecture
3-D-SL-01
Kenji Kamiya (Japan)
Q
Luncheon Seminar7
3-D-LS-7
Recent Advances in Radiotherapy
for Prostate Cancer
AstraZeneca K.K.
Eye Opener
Room E
3-E-EO-11
Non-ionizing Radiation
Radiation-induced Effects
Compromise The DNA
Polymerase and Ligation
Steps in DNA Repair
Environment Stressors
Samuel H. Wilson
(United States)Q
Symposium
3-E-SY-22-01∼05
Processing of Oxidized DNA Damage
Q
Eye Opener
Annex 1
Radiation Oncology
Congress Lecture
3-AX1-EO-13
Overall Treatment
Time in Fractionated
Radiotherapy
Boguslaw A.
Maciejewski
(Poland)Q Symposium
3-AX1-SY-25-01∼07
【Prof. Withers' Memorial Symposium】
Dose Fractionation: From Hyperfractionation to Hypofractionation
Q
Annex 2
Biology for Radiation Therapy
Event Hall
Avraham Eisbruch
(United States)
Q
Luncheon Seminar9
3-AX1-LS-9
Dynamic Tumor Tracking
using the Elekta Agility MLC
Elekta K.K.
Luncheon Seminar6
3-AX2-LS-6
Symposium
3-AX2-SY-20-01∼06
Educational Seminar: Radiobiology Updates
for Radiation Oncologists
Q
Poster Dismantle
3-AX1-CL-11
IMRT for HN Cancer:
Emphasis on Reducing
Xerostomia and Dysphagia
Poster Mounting
What about CyberKnife
and TomoTherapy ? The
《Daily Life》Arguments
Accuray Japan K.K.
Poster Display
2-
A- SY1
DAY 2
13:00
RoomA
30
Session Number
14:00
30
EO: Eye Opener
OS: Oral Session
P: Plenary
SY: Symposium
LS: Luncheon
PS: Poster Session
CL: Congress Lecture
15:00
30
16:00
30
17:00
30
18:00
Congress Lecture
3-A-CL-12
Neoplasia in Mice Chronically
Exposed to Very Low
Dose-rates of Gamma-Rays
Ignacia Tanaka
(Japan)Q
Symposium
3-A-SY-28-01∼04
Omics Approach to Low-dose/
Low-dose-rate Radiation Studies
Q
Oral Session09
3-A-OS-09-01∼05
Low Dose Radiation Effects
Q
Congress Lecture
3-B1-CL-20
Lessons Learned from
Radiation Health Risk
Management around
Chernobyl and in Fukushima
Shunichi Yamashita
(Japan)Q
Symposium
Oral Session17
Lessons Learned in Health and Medical Aspects: From A-bomb and
Chernobyl to Fukushima
Q
Environmental and Health
Effects of Fukushima Nuclear
Power Plant Accident
Q
3-B1-SY-36-01∼06
3-B1-OS-17-01∼05
Congress Lecture
3-B2-CL-16
Molecular Responses to
Low Dose and Low
Dose Rate Radiation
Gayle E Woloschak
(United States)Q
Symposium
3-B2-SY-32-01∼05
New Perspectives in Epidemiological Studies of Low Dose Exposure and
Cancer Risk
Q
Oral Session13
3-B2-OS-13-01∼05
Epidemiology
Q
Congress Lecture
3-C1-CL-17
Ultrafast Oxidation
Reaction Induced by
Radical Cation H22O+.
Mehran Mostafavi
(France)
Symposium
Oral Session14
New Prospect of Radiation Science on Nanotechnology, Electron
Collision with Matter, and Positronium
Q
Radiation Processing and
Nanolithography
3-C1-SY-33-01∼05
3-C1-OS-14-01∼05
Congress Lecture
3-C2-CL-19
Development and
Current Status of
Area Detector CT
Kazuhiro Katada
(Japan)Q
Symposium
3-C2-SY-35-01∼04
Functional Imaging Using CT
Q
Oral Session16
3-C2-OS-16-01∼05
Particle
(Biology and Clinical)
Congress Lecture
3-D-CL-14
Repair of DNA Double-strand
Breaks by Homologous
Recombination
Markus Lobrich
(Germany)
Q
Symposium
Oral Session11
Radiation-induced DNA Damage Response and Cell Death
Q
DNA Repair-1
Q
3-D-SY-30-01∼04
3-D-OS-11-01∼05
Congress Lecture
3-E-CL-15
An Integrated View of
Induced Mutagenesis
Robert P Fuchs
(France)
Q
Symposium
Oral Session12
Combined Exposure of Ionizing Radiation and Chemicals
Q
Radiosensitization
3-E-SY-31-01∼04
3-E-OS-12-01∼05
Congress Lecture
3-AX1-CL-18
Recent Advances in Radiation
Therapy for Lung Cancer
Ritsuko Komaki
(United States)
Q
Symposium
3-AX1-SY-34-01∼05
Radiation Oncology Update: Chemoradiotherapy
Q
Oral Session15
3-AX1-OS-15-01∼05
Radiation Biology and Imaging
Congress Lecture
3-AX2-CL-13
Update on Cancer Stem
Cells and Radioresistance
Richard P Hill
(Canada)
Symposium
3-AX2-SY-29-01∼05
Radiosensitization in Clinical Oncology
Q
Poster Display
Oral Session10
3-AX2-OS-10-01∼05
Radiosurgery and Tumor Hypoxia
Poster Session 2
*Light meal is to be served
(sponsored)
Program-at-a-Glance
8:00
30
9:00
Day4 Thursday, May 28
30
10:00
30
11:00
Eye Opener
Room A
Biological Effects
Room B-1
Particle Therapy
Room B-2
4-A-EO-16
Dose Rate Effects in Radiation
Carcinogenesis: A Look from
Hiroshima/Nagasaki to
Fukushima
Hiroshi Tanooka
(Japan)Q
Eye Opener
4-B1-EO-24
Life Sciences
Room E
Space Radiation
Annex 1
Radiation Oncology
Annex 2
Biology for Radiation Therapy
Event Hall
Topics in Physics and Biology for Particle Therapy
Q
Symposium
Impact of Ionizing
Radiation on
Environmental Biota
Current Situation and Issues on Dose Assessment for Natural Radiation Exposure
Special Expenditures Project of Ministry of Education, Culture, Sports,
Science and Technology Advanced Human Resources Development
Project for Radiation Emergency Medicine
Q
4-B2-EO-20
Eye Opener
Room D
4-B1-SY-45-01∼04
Eye Opener
Room C-1
BNCT
Symposium
Takashi Nakano
(Japan)Q
Kathryn A. Higley
(United States)Q
Room C-2
Molecular Mechanisms of Radiation Carcinogenesis in Animal Models
Q
Current Status of
Carbon Ion Therapy
for Cancers
Radiation Protection Sciences
Radiation Chemistry
Symposium
4-A-SY-37-01∼04
Michael D Sevilla
(United States)
Q
12:00
30
13:00
AW05-ARR
Definition of Clinical Dose and
Hypoxia and Tumour Cell QA for Carbon Ion Therapy
Radiosensitivity
Mitsubishi Electric Corporation
Ian J Stratford
(United Kingdom) JRRS Special Session
JRRS President Lecture
AW06-JRRS
Attracted to Radiation Biology:
From Thorotrast to The Future
Manabu Fukumoto
(Japan)
4-B2-SY-41-01∼05
4-C1-EO-21
Free Radical Mechanisms of
Radiation Damage to DNA
30
Award Lecture
The Weiss Medal Luncheon Seminar10
(Weiss Medal) by ARR
4-A-LS-10
Symposium
4-C1-SY-42-01∼05
Progress in Radiation Chemistry and Dosimetry in Biological Materials
Q
Oral Session18
4-C1-OS-18-01∼05
Radiation Dosimetry and
Biological Materials
Eye Opener
4-C2-EO-23
The Principle and History of
Neutron Capture Therapy
Junichi Hiratsuka
(Japan)
Symposium
4-C2-SY-44-01∼05
Clinical Study of BNCT
Q
Luncheon Seminar12
Eye Opener
4-D-EO-18
Nuclear Topography of
Homologous
Recombinational Repair
Satoshi Tashiro
(Japan)Q
4-D-LS-12
Role of Low-Dose CT in
Addressing Social Concerns
Regarding Radiation Exposure
Following Nuclear Accidents
Symposium
4-D-SY-39-01∼06
Frontiers of Radiation Research
Q
Toshiba Medical Systems Corporation
Eye Opener
4-E-EO-19
Life Science Experiments
Performed in Space in
the ISS/Kibo Facility and
Future Plans
Takeo Ohnishi
(Japan)Q
Symposium
4-E-SY-40-01∼06
Early and Late Biological Effect of Space Radiation
Q
ICRR Special Lecture
Eye Opener
4-AX1-EO-22
Eye Opener: Progress of
RT for Moving Targets
Dirk L.J. Verellen
(Belgium)
Q
Eye Opener
4-AX2-EO-17
Tumor Microvasculature
as Target of Therapy
Chang W. Song
(United States)
Q
Poster Dismantle
Symposium
4-AX1-SY-43-01∼05
Advanced IGRT System for Motion Control
Q
Symposium
4-AX2-SY-38-01∼04
International Symposium of Tumor Control by
Radiation: Biology for Stereotactic Irradiation
Q
Poster Mounting
4-AX1-SL-02
The Evolution of
Radiation Therapy;
from 3D to 4DRT
Masahiro Hiraoka
(Japan)Q
Luncheon Seminar13
4-AX1-LS-13
IMRT & Rapid Arc in
Gynecologic Tumors
Varian Medical Systems K.K.
Luncheon Seminar11
4-AX2-LS-11
Application of the iPS Cell
Technology for
Musculoskeletal Diseases
Daiichi Sankyo Company, Limited
Poster Display
2-
A- SY1
DAY 2
13:00
RoomA
30
Session Number
14:00
30
EO: Eye Opener
OS: Oral Session
P: Plenary
SY: Symposium
LS: Luncheon
PS: Poster Session
CL: Congress Lecture
15:00
30
16:00
30
17:00
30
18:00
Congress Lecture
4-A-CL-21
Cell of Origin in
Radiation-induced
Premalignant Thymocytes
Ryo Kominami
(Japan)Q
Symposium
4-A-SY-46-01∼05
Hiroshima University RIRBM Joint Usage /Research Center Symposium
Molecular Mechanisms of Radiation-induced Cancer
Q
Congress Lecture
4-B1-CL-29
Novel Personalized Care for
Strategies for Prostate
Cancer and Glioma Patients
Arnab Chakravarti
(United States)
Symposium
4-B1-SY-54-01∼04
Clinical Researches of Particle Therapy;
Strategy for the Advanced Particle Therapy
Q
Congress Lecture
4-B2-CL-25
Armed Forces Radiobiology
Research Institute Program:
Accomplishments,
Opportunities, Policy Questions
Mark H Whitnall
(United States)Q
Symposium
4-B2-SY-50-01∼05
Phoenix Leader Education Program (Hiroshima Initiative) for
Renaissance from Radiation Disaster
Protection and Prospect in Radiation Disaster
Q
Congress Lecture
4-C1-CL-26
Radiation Chemistry in
Nuclear Accident after
Fukushima Accident
Yosuke Katsumura
(Japan)Q
Congress Lecture
4-C2-CL-28
The Current State and
Future Prospect of BNCT
Koji Ono (Japan)
Symposium
4-C1-SY-51-01∼05
Radiation and Radiochemistry in Nuclear Research and Nuclear Accident
Q
Symposium
4-C2-SY-53-01∼05
Boron Delivery to Tumors
Q
Gala Dinner at
TOEI Kyoto Studio Park
Congress Lecture
(Starting around 18:00)
Q
4-D-CL-23
DNA Damage in Micronuclei
Generates Chromothripsis and
Other Complex Chromosomal
Rearrangements
Alexander Spektor
(United States) Q Symposium
4-D-SY-48-01∼05
Re-evaluation of Biological Targets of Radiation-induced Cell Killing
Q
Congress Lecture
4-E-CL-24
Track Structure Effects in
Galactic Cosmic Ray
Induced Cancer and Central
Nervous System Risks
Francis A Cucinotta
(United States)Q Symposium
4-E-SY-49-01∼06
Physical Dosimetry for Space Radiation
Q
Congress Lecture
4-AX1-CL-27
Recent Advances in
Radiation Therapy for
Prostate Cancer
Deborah A Kuban
(United States)
Q
Symposium
4-AX1-SY-52-01∼05
Radiation Therapy in the Era of IMRT
Q
Congress Lecture
4-AX2-CL-22
The Impact of Hypoxia and
Its Modification on The
Outcome of Radiotherapy
Michael R. Horsman
(Denmark)
Symposium
4-AX2-SY-47-01∼05
International Symposium of Tumor Control by Radiation:
Recent Progress in Targeting Hypoxic Tumor Cells: From Bench to Clinic Q
Poster Display
Poster Session 3
*Snacks is to be served
(sponsored)
Program-at-a-Glance
8:00
30
9:00
Day5 Friday, May 29
30
10:00
30
11:00
30
12:00
Eye Opener
Room A
Biological Effects
Munira A. Kadhim (United Kingdom)Q 13:00
Luncheon Seminar14
5-A-EO-25
Recent Studies on Bystander
Effects: Role of Exosomes
Cargo in Intra- and
Intercellular Communication
30
Symposium
Oral Session19
The Role of Reactive Oxygen Species in Radiation Response
Q
Cellular Effects
Q
5-A-SY-55-01∼05
5-A-OS-19-01∼05
5-A-LS-14
Early Clinical Experience of
Real-Time Tumor-tracking
Radiotherapy (RTRT) with SyncTraX
Shimadzu Corporation
Eye Opener
Room B-1
Biology for Radiation Therapy
5-B1-EO-33
Alterations of Tumour
Vasculature: Effect on Tumour
Proliferation, Hypoxia and
Radiation Response
Ruth J Muschel (United Kingdom)Q Symposium
Oral Session27
Cell Cycle Regulation in Radiotherapy
Q
Radiosensitivity-2
5-B1-SY-63-01∼04
5-B1-OS-27-01∼05
Eye Opener
Room B-2
Radiation Protection Sciences
5-B2-EO-29
Stem Cell Therapy for the
Treatment of Severe
Tissue Damage after
Radiation Exposure
Marc Benderitter
(France)Q
Symposium
Oral Session23
Benefit Risk Communication
Q
Biological Dosimetry
Q
5-B2-SY-59-01∼03
5-B2-OS-23-01∼03
Eye Opener
Room C-1
Physical Processes
5-C1-EO-30
Dissociation of Ionized
Biomolecules: Ab Initio
Molecular Dynamics
Studies
Marie Anne Herve du Penhoat
(France)
Symposium
5-C1-SY-60-01∼04
Oral Session24
5-C1-OS-24-01∼05
Physical Process of Radiation Damage to Biomolecules
and its Cellular Consequences
DNA Damage Response-2
Symposium
Oral Session26
Development of Neutron Source and Measurement
Q
BNCT&Particle (Physics)
Eye Opener
Room C-2
BNCT
Room D
Life Sciences
Room E
Electro - Magnetic Field
Annex 1
Radiation Oncology
Annex 2
Radiation Oncology
Event Hall
5-C2-EO-32
The History of the
Development of Neutron
Source for Boron Neutron
Capture Therapy
Yoshinori Sakurai
(Japan)
Eye Opener
5-D-EO-27
Role of Abscopal Effect in
Radiation Carcinogenesis
Tom K. Hei
(United States)
Q
5-C2-SY-62-01∼04
5-C2-OS-26-01∼05
Luncheon Seminar16
Symposium
5-D-SY-57-01∼05
Recent Progress in Microbeam Research - Non-targeted Effects on
Cells/Tissues Surrounding Irradiated Cells
(Joint Session with the 12th International Workshop on Microbeam
Probes of Cellular Radiation Response (IWM2015)
Q
Oral Session21
5-D-OS-21-01∼05
DNA Repair-2
Q
Eye Opener
5-E-EO-28
Electromagnetic Fields
and Cancer: Current
State of Knowledge and
Challenges
Joachim C Schuz
(France)Q
Symposium
Oral Session22
Biological Effects of Electromagnetic Field
Q
Radiation-induced
Carcinogenesis
Q
5-E-SY-58-01∼05
5-E-OS-22-01∼05
Oligometastatic Disease
and Stereotactic Body
Radiotherapy (SBRT)
Umberto Ricardi
(Italy)Q
Imaging-based
Adaptive Radiotherapy
K.S. Clifford Chao
(United States)
Q
Luncheon Seminar17
5-E-LS-17
3D γ -analysis for IMRT/VMAT
Plan QA Using an EPID Based
Dose Reconstruction
Toyo Medic K.K.
5-AX1-LS-18
Symposium
5-AX1-SY-61-01∼05
Most Updated Clinical Evidence of SBRT
Q
Clinical Approach on
State-of-the-Art
5-AX1-OS-25-01∼05
Radiation Therapy
SBRT
- Not Only for Primary But
Also for Metastases -
Oral Session25
Brainlab K.K.
Luncheon Seminar15
Eye Opener
5-AX2-EO-26
Hitachi Medical Corporation
Luncheon Seminar18
Eye Opener
5-AX1-EO-31
5-D-LS-16
Tomotherapy - History,
Present Status, and Future
Perspective in Japan -
Symposium
5-AX2-SY-56-01∼05
Adaptive Radiation Therapy
Q
Poster Dismantle
5-AX2-LS-15
Oral Session20 Local Measures of Tumor Response
5-AX2-OS-20-01∼05
Chest and Head & Neck
to Therapy Using Deformable
Registration of FDG PET
Euro Meditech Co., Ltd
2-
A- SY1
DAY 2
13:00
RoomA
30
Session Number
14:00
30
Closing
Ceremony
Q
EO: Eye Opener
OS: Oral Session
P: Plenary
SY: Symposium
LS: Luncheon
PS: Poster Session
CL: Congress Lecture
15:00
30
16:00
30
17:00
30
JRRS General Meeting (In Japanese)
Award Ceremony 2015
Award Lectures 2014
Award Lecture
Henry S. Kaplan Distinguished Scientist
Award (Kaplan Award) by IARR
AW07-IARR
Attempts to Connect Radiation Epidemiology
of Cancer among the Atomic Bomb Survivors
to Radiation Biology
Ohtsura Niwa (Japan)Q
Satellite Workshop in ICRR2015: Updating
the dose reconstruction for residents in
Fukushima Nuclear Accident
Q
Sponsored Symposium
5-AX1-SS-01
EDGE ™ : A One-Stop Solution
for the Treatment of Intra-Cranial
and Extra- Cranial
Oligometastatic Disease
Varian Medical Systems K.K.
Sponsored Symposium
5-AX1-SS-02
A New Horizon of Radiotherapy
Expanded by Hypofractionated
Irradiation
Accuray Japan K.K.
Sponsored Symposium
5-AX1-SS-03
MRI-guided Radiotherapy: On-line
MRI for Treatment Guidance
Elekta K.K.
18:00
I-1.
ICRR2015
15
15th International Congress of Radiation Research
2015
4
5
25
ICRR2015
29
1
ICRR
1979
6
Japanese
Association for Radiation Research JARR
2
ICRR
JARR
2009
International Association for Radiation Research
IARR)
Councilor Meeting
ICRR2015
ICRR2015
JARR
IARR
Society)
RRS(Radiation Research Society)
ERRS(European Radiation Research
AARR(Asian Association for Radiation Research)
ESTRO, ASTRO
6
67
128
61
ICRR2015
33
ICRR2015
Advisory board
“Radiation Science Shaping the Future of the Earth and Mankind”
Radiation Science
ICRR2015
Radiation Science
ICRR2015
ICRR2015
ICRR
iPS
European Radiation Research Society
13
ICRR2015
53
2,016
463
132
987
ICRR
ICRR2015
2014
Travel+Leisure
Gala Dinner
Get Together for Young Investigators
ICRR2015
1,119
I-2. JARR
Welcome to Kyoto Japan. The last time the International Congress of Radiation Research was held in Japan
was the 6th Congress in Tokyo in 1979. The members of the Japanese Association for Radiation Research, the
JARR, represent researchers in many fields of Radiation Biology, Radiation Chemistry, Radiation Physics,
Environmental Radiation and Radiation Medicine. The JARR proposed to hold this congress in Japan several
times, and we have been hoping to host this meeting for a very long time. Today, we are honored to have finally
succeeded, and are once again hosting this ICRR. We are very enthusiastic at being able to host this Congress
for the second time this year, the 15th ICRR in Kyoto, Japan. As president of the JARR, I appreciate the
generous contributions made by the president, Dr. Masahiro Hiraoka and all of the members of the organizing
committee, and I would like to congratulate them for the successful outcome of their efforts at the opening of the
15th ICRR.
More than 100 years ago, Wilhelm Conrad Röntgen recognized the phenomenon of radiation, and Maria
Sk odowska-Curie identified radioisotopes, and they both received a Nobel prizes for their work. Since that time,
many scientists have studied radiation, and have applied their observations and insights to many areas, including
human health. This is reflected in recent progress in studies of radiation and radioisotopes which have been very
useful in medical fields and in improving human lives. We would like to note that there has been remarkable
progress in the understanding of radiation, and also in applying these new insights in radiation and radioisotopes
to the studies of biological systems at the molecular level. However, in contrast to these hopes, the huge
earthquake and Tsunami in Eastern Japan on March 11th, 2011 led to the subsequent Fukushima nuclear power
plant accident. This disaster resulted in the release of a substantial quantity of radioisotopes into the atmosphere.
Since the Fukushima accident happened, Japan has intensively studied the effects of radiation and radioisotopes
in efforts to protect human health. In addition, efforts to educate the general population about radiation and its
effects have become more important. Therefore, the opening of this congress is very significant for Japan. I hope
that elevated levels of scientific presentations and discussions on the benefits and risks of radiation and
radioisotopes during this congress will further advance all of our fields. I also hope that the scientific
presentations and discussions during the ICRR will result in benefits to people all around the world. Welcome to
Japan and to Kyoto. We hope you will enjoy the scientific presentations at the ICRR and Japanese culture in
Kyoto. Thank you very much.
1979
6
(ICRR)
JARR
(IARR)
ICRR
ICRR
(AARR)
1
(ACRR)
2009
2
ACRR
2015
ICRR
4
2005
2011
ICRR
2011
ICRR
5
2011
3
11
ICRR
2015
ICRR
JARR
ICRR
(
)
ICRR
2,000
ICRR
ICRR
I-3. Message from IARR*
IARR president at the time of ICRR2015
Marco Durante
Professor Hiraoka, dear Colleagues.
I’d like to personally welcome each of you to the 15th International Congress of Radiation Research.
Thank you for coming. That many of you travel long distances – including myself! - serves to remind us all
just how important our work is.
Radiation research is an exciting area in which to work and study, and we’ll continue to meet and bring
inspired people and young students together in forums like this, to ensure our organization remains at the cutting
edge.
Let me give you a brief update on where we are today. The last ICRR meeting was in Warsaw, and started
only a few months after the Fukushima accident. After four years we meet here, in Japan, and our first thought
must go to the thousands of victims who were killed in the devastating earthquake and tsunami on March, 11,
2011.
I will borrow the words from Haruki Murakami, a famous writer from Kyoto:
“It's a terrible thing when a person dies, whatever the circumstances. A hole opens up in the world, and we
need to pay the proper respects. If we don't, the hole will never be filled in again.”
In the past four years, the Japanese Radiation Research community, and along with them radiation researchers
all over the world, paid the proper respect to those victims. Radiation protection studies have greatly enhanced
our knowledge and understanding of the effects of low doses of ionizing radiation, and in this meeting we will
learn about the most recent studies in radioprotection and radioecology in the aftermath of the Fukushima
tragedy, also in the satellite workshop on dose reconstruction in Fukushima following the ICRR.
It is an exciting time for radiation therapy, too. In the past four years, we have seen a rapid growth of
stereotactic body treatments, with hypofraction now becoming a standard in clinical practice. Charged particle
therapy is rapidly growing all over the world, and Japan has pioneered this technique. The National Institute for
Radiological Sciences in Chiba, the first institute to treat patients with high-energy carbon ions, celebrated 20
*
Durante IARR
ICRR2015
ICRR2015
years of clinical treatments last year, and its example has been followed by several other centers outside Japan:
in China, in Europe, and in the next four years also in USA.
In the next few days, you will have the opportunity to hear all the recent advances in radiation research. With
33 conference lectures, 33 eye openers, 63 Symposia, 27 oral sessions, 18 luncheon seminars, and hundreds of
posters, you will always find something interesting and new for you. Prepare yourself to be challenged, excited
and inspired.
This is my last week as President of the International Association for Radiation Research. The new President
will close this meeting and announce the next one in 2019. There are many people I would like to thank for
giving me this honor and helping me in this office. “I want to thank everyone I ever met in my whole life” said
Maureen Stapelton winning her Academy Award – that’s how I feel as well, but there is no much time! Certainly
I want to thank the Treasurer-Secretary of the Society, Prof. Gianfranco Grossi, who is also stepping down, and
the past President, Prof. Ohtsura Niwa. He is the well-deserved recipient of the Kaplan award, and you will have
the opportunity to listen to his seminar on Friday.
Before I close, I’d like to thank again each of your for attending our conference and bringing your expertise to
our gathering. You have the vision, the knowledge, the wherewithal and the experience to pave our way into the
future. Throughout this conference, I ask you to stay engaged, keep us proactive and help us shape the future of
radiation research. My personal respect and thanks goes out to all of you. Domo arigato gozaimashita.
I-4.
Advisory Board
JARR
IARR
Durante, Marco
Helmholtzzentrum für Schwerionenforschung, Germany
Barcellos-Hoff, Mary Helen
New York University School of Medicine, USA
Grossi, Gianfranco University Federico II, Italy
RRS
Cucinotta, Francis A. University of Nevada Las Vegas, USA
Hei, Tom K.
Columbia University, USA
Blakely, Eleanor A. Lawrence Berkeley National Laboratory , USA
Haynes, Veronica
Radiation Research Society, USA
ERRS
Jones, George Don University of Leicester, UK
Dörr, Wolfgang
Medical University of Vienna, Austria
Baatout, Sarah
SCK-CEN Belgian Nuclear Research Centre, Mol, Belgium
Manti, Lorenzo
Universita di Napoli Federico II, Italy
AARR
Mishra, Kaushala P. Indian Society for Radiation Biology, Nehru Gram Bharati University, India
Ji, Yanqin
National Institute for Radiological Protection, China
ASTRO
Haffty, Bruce G.
Robert Wood Johnson Medical School, New Brunswick, N.J., USA
ESTRO
Poortmans, Philip
Radboud University Medical Centre, Netherlands
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
IARR
Durante, Marco
Helmholtzzentrum für Schwerionenforschung, Germany
Barcellos-Hoff, Mary Helen
New York University School of Medicine, USA
Grossi, Gianfranco University Federico II, Italy
Brenner, David
Columbia University Medical Center, USA
Cebulska-Wasilewska, Antonina
Choi, Eun Kyung
The Henryk Niewodniczanski Institute of Nuclear Physics, Poland
University of Ulsan, College of Medicine and Asan Institute for Life Sciences, Republic of
Korea
Coppes, Rob P.
University of Groningen, The Netherlands
Hill, Richard P.
Ontario Cancer Institute - Princess Margaret Hospital, Canada
Jones, George Don University of Leicester, UK
Kazymbet, Polat
Astana Medical University, Kazakhstan
Kimler, Bruce
University of Kansas Medical Center, USA
Lyng, Fiona M.
Dublin Institute of Technology, Ireland
Pan, Ziqiang
China National Nuclear Corporation, China
Paretzke, Herwig
Institute of Radiation Protection, Germany
Rezvani, Mohi
The University of Reading Whiteknights, UK
Simone, Giustina
Italian National Institute of Public Health, Italy
Sminia, Peter
VU University Medical Center, The Netherlands
Williams, Jacqueline P. University of Rochester Medical Center, USA
Williams, Kaye J.
University of Manchester, UK
RRS
Bailey, Susan M.
Colorado State University, USA
Barcellos-Hoff, Mary Helen
Buettner, Gary R.
NYU School of Medicine, USA
University of Iowa, USA
Coleman, Norman National Cancer Institute, USA
Costes, Sylvain V. Lawrence Berkeley National Laboratory, USA
Harrison, Lynn
Louisiana State University, USA
Hauer-Jensen, Martin
Kirsch, David
Morgan, William F.
O’Neill, Peter
Univeristy of Arkansas, USA
Duke University Medical Center, USA
Pacific Northwest National Laboratory, USA
Gray Institute for Radiation Oncology and Biology, UK
Weil, Michael
Colorado State University, USA
Woloschak, Gayle E. Northwestern University Medical School, USA
Williams, Jacqueline P. University of Rochester Medical Center, USA
ERRS
Jones, George Don University of Leicester, UK
Baatout, Sarah
SCK-CEN Belgian Nuclear Research Centre, Mol, Belgium
Bentomane, Mohammed Abderrafi
SCK-CEN Belgian Nuclear Research Centre, Mol, Belgium
Dörr, Wolfgang
Medical University of Vienna, Austria
Elmroth, Kecke
Göteborg University, Sweden
Franken, Klaas
University of Amsterdam, Netherlands
Hofer, Michal
Academy of Sciences of the Czech Republic, Brno, Czech Republic
Janiak, Marek K.
Military Institute of Hygene and Epidemiology, Warszawa, Poland
Lumniczky, Katalin National Research Institute for Radiobiology and Radiohygiene, Budapest, Hungary
Manti, Lorenzo
Universita di Napoli Federico II, Italy
Pantelias, Gabriel
NCSR Demokritos, Athens, Greece
Voisin, Philippe
Institute de Radioprotection et de Surrete Nucleaire Fontenay-aux-Roses Cedex, France
AARR
Bahtin, Meirat
Institute of radiobiology research, JSC Medical University Astana, Kazakhstan
Guo, Guozhen
The Fourth Military Medical University, China
Hande, M. Prakash National University of Singapore, Singapore
Kazymbet, Polat
Institute of radiobiology research, JSC Medical University Astana, Kazakhstan
Kim, In Ah
Seoul National University, Korea
Lee, Jae-Seon
Korea Institute of Radiological & Medical Sciences, Korea
Pandey, B.N.
Radiation Biology and Signaling Section, Bhabha Atomic Research Center, India
Prapunsri, Chowunchun
Neutron and Radiation Technology Research Center (Currently, Nuclear
Engineering Seibersdorf GmbH, Austria), Thailand
Wu, Guozhong
Shanghai Institute of Applied Physics, Chinese Academy of Sciences, China
Zhou, Pingkun
Beijing Institute of Radiation Medicine, China
ASTRO
Haffty, Bruce G.
Robert Wood Johnson Medical School, New Brunswick, N.J., USA
Dawson, Laura A. Princess Margaret Hospital, Toronto, Canada
Harari, Paul M.
University of Wisconsin, USA
Martel, Mary K.
The Univeristy of Texas MD Anderson Cancer Center, Houston, USA
Timmerman, Robert UT South Western Medical Center, USA
ESTRO
Jornet, Nuria
Hospital de Sant Pau, Barcelona, Spain
Wouters, Brad
Princess Margaret Hospital, Canada
Zips, Daniel
University Hospital and Faculty of Medicine Tübingen, Germany
ICRR2015
I-5.
I-6.
15
ICRR2015
ICRR
JARR
36
ICRR
No. 1 98
3
2014
5
17
Vol. 50
8
ICRR2015
ICRR2015
ICRR2015
ICRR2015
2011
11
5
2014
3
9
9
ICRR2015
ICRR2015
Track
3
1119
ICRR2015
Plenary Lecture
28
Gala Dinner
Social Program
JARR
ICRR
Dinner
ICRR
ICRR2015
70
70
2011
36
3
11
ICRR
2012
ICRR2015
I-7.
ICRR2015
2009
2010
2010
7
3
6
JARR
2011
2
12
10
Secretary General
ICRR2011
ICRR2015
ICRR2011
2011
11
19
10
1
2012
2
11
12
2
2
Local Committee
6
9
3
3
27
8
11
WG
2013
5
4
9
2
2
5
2
11
10
4
Vice President
6
8
6
17
5
2013
9
ERRS
RRS
7
17
9
2014
2
5
18
8
8
17
8
RRS
9
2015
4
18
18
8
I-8.
ICRR2015
iPS
iPS
Eye Opener
DNA
DNA
ICRR2015
1119
132
107
135
ICRR
3
5
27
Get Together for Young Investigators
ICRR
IARR
Henry S. Kaplan Distinguished Scientist
Award
ICRU
Research
Gray Medal Association for Radiation
Weiss Medal
ERRS
Bacq and Alexander Award
ICRR
ICRR
National Institutes of Health (NIH)/National Cancer Institute (NCI)
I-9.
1
2012
11
5
2
2013
3
JARR
2013
9
2
8
1
ICRR
2013
2014
12
1
1
ICRR
2014
2014
8
2014
12
2015
2
ICRR
2
I-10.
2011
2013
10
11
19
7
ICRR
14
JRRS
JASTRO
ASTRO
ESTRO
ICRB
JRRS
JRS
JHPS
FARO
JSMP
FARO
ASTRO, ESTRO
AARR
JSRC
2013
RRS
JRRS
JASTRO
11
2014
6
14
UDX
2014
7
ICRR2015
2014
4
ICRR2015
6
A2
20
A2
15
A4
JASTRO
JASTRO
ERRS 2014 RRS SEAROG-ESTRO JASTRO
ICRB
plenary session
ICRR2015
ICRR2015
20
JRRS
57
AOCR
JRRS
ICRR2015
ICRR2015
ICRR2015
JASTRO Newsletter
RRS
JHPS
ICRR2015
JRRS
JNRS JASTRO JRS RRS ERRS
ICRR2015
RRS
RRS
ICRR
ICRR2015
ICRR2015
2012
2013
RRS
60
RRS
RRS
Woloschak RRS
E Pullman
F Cucinotta
T Hei
V Haynes A Rinehart
ICRR2015
9
ICRR2015
G
22
ICRR
RRS
track
invitation letter
one
person one job
RRS
RRS
ICRR2015
IARR
ERRS
ICRB
JRRS
44
21
2014
12
8
1
58
53
ERRS
ICRR2015
1
10
ICRR
Travel+Leisure
AARR: Asian Association for Radiation Research, AOCR: Asian Oceanian
Congress of Radiology, ASTRO: American Society for Radiation Oncology, ERRS European
Radiation Research Society, ESTRO: European Society for Radiotherapy & Oncology, FARO:
Federation of Asian Organizations for Radiation Oncology, HPS: Health Physics Society, ICRB:
International Conference on Radiation Biology, IRPA:
International
JASTRO:
, JNRS:
JRS:
JSRC:
Radiation
Protection
Association,
, JHPS:
, JRRS:
, JSMP:
,
,
, RRS: Radiation Research Society,
SEAROG: South East Asia Radiation Oncology Group
ICRB2014
A2
A4
2014/4/4-8
33
ESTRO
2014/4/10-13
73
JRS
2014/5/31-6/1
16
JASTRO
2014/6/7
20
2014/6/14-19
16
2014/6/17-18
15
2014/6/19-20
47
2014/6/23-27
4
2014/7/7-9
52
2014/7/11-12
43
JASTRO
2014/7/13-17
59
HPS
2014/8/9-11
11
2014/8/28-30
52
2014/8/30-31
16
2014/9/8-11
5
2014/9/11-13
58
2014/09/14-17
56
ASTRO
2014/9/14-19
41
ERRS
2014/9/21-24
60
RRS
2014/9/25-27
108
2014/9/25-27
73
2014/9/26-28
50
JRS
2014/9/24-28
15
AOCR
2014/10/1-3
57
JRRS
2014/10/5-9
11
Ionizing Radiation and Polymers Symposium
JHPS
IRPA
52
2014/7/19-20
JASTRO
JNRS
JSMP
2014/10/17
2014/10/23-25
14
2014/11/2-6
SEAROG-ESTRO2014
2014/11/11-13
ICRB 2014
2014/12/11-13
27
2015/1/31
5
2015/2/20-21
30
2015/4/16-19
74
2015/4/16-19
109
2015/4/24-28
3
-
JASTRO
JASTRO
JRS
JSMP
ESTRO Forum
I-11.
ICRR
ICRR
ICRR
12
(IWM2015)
th
The 12 International Workshop on Microbeam Probes of Cellular Radiation Response
5
30
6
1
68
154
102
52
STED
DNA
( )
8
th
8 International Symposium on Physical, Molecular, Cellular, and Medical Aspects of Auger Processes
5
20
22
21
16
11
X
2
DNA
DNA
X
DNA
2
ESRAH2015
The 2nd Educational Symposium on RADIATION AND HEALTH by Young Scientists (ESRAH2015).
5 23
24
106
106
Christian Streffer
Tibor Kovács
Gerry Kendall
Andrzej Wojcik
5
2015
Space Radiation and Heavy Ions in Therapy Symposium 2015 (SRHITS2015)
5 22
24
25
70
93
75
18
2013
HITSRS 2013
15 IBIBAM
7 IWSRR
JAXA
20
2
DNA
KKR
/
The 1st International Workshop on Sample/Tissue Archiving of Radiobiology (STAR2015)
5
24
Annex
17
9
2015
Stem Cell and Radiation Carcinogenesis Workshop 2015
5
25
Room501
44
7
4
37
ICRP
Stem Cell Biology with Respect to Carcinogenesis
Aspects
in vitro
in vivo
(
)
ICRR2015
Satellite Workshop in ICRR2015: Updating the dose reconstruction for residents in Fukushima Nuclear
Accident
2015
37
5
29
7
14:30-16:30
B-2
30
UNSCEAR2013
WS
JAEA
UNSCEAR
WSPEEDI
WBC
I-129
UNSCEAR2013
I-131
M. Hort
A. Bouville
W. Roehm
I-12.
“
2014
2
No1
Gala Dinner
B
ICRR2015
”
I-13.
ICRR2015
I-13.1.
1
Argentina
2
2
Australia
11
2
3
Austria
6
6
4
Belarus
1
1
5
Belgium
5
5
6
Brazil
1
1
7
Cameroon
8
Canada
22
3
9
China
42
18
10
Congo
1
2
1
3
1
17
11
2
1
1
25
1
2
63
1
11
Czech Republic
6
1
12
Denmark
9
1
1
11
7
13
Finland
4
14
France
45
10
2
57
15
Germany
58
11
4
74
16
Ghana
1
3
4
17
Greece
2
18
Hong Kong
4
1
5
4
1
2
19
Hungary
4
2
20
India
4
5
21
Indonesia
1
7
22
Iran
2
6
2
1
10
1
11
2
23
Ireland
24
Israel
2
25
Italy
14
1
26
Japan
749
246
2
3
3
50
3
18
41
1086
27
Kazakhstan
28
Korea
45
2
29
Kuwait
1
1
30
Latvia
2
2
31
Malaysia
2
32
New Zealand
4
33
Nigeria
1
34
Norway
3
35
Philippines
36
Poland
13
2
26
71
5
7
4
1
2
1
6
6
6
1
14
37
Portugal
1
1
1
2
38
Qatar
39
Romania
10
2
12
1
40
Russia
14
2
16
41
Saudi Arabia
4
42
Singapore
1
43
South Africa
1
44
Spain
45
Sweden
46
Switzerland
47
Taiwan
48
Thailand
49
The Netherlands
4
13
14
1
2
1
12
9
3
2
1
1
27
33
8
4
18
6
50
Turkey
1
51
Ukraine
6
1
31
4
199
6
52
United Kingdom
53
United States
60
12
1
1440
1
5
4
39
7
217
33
440
60
76
Accompanying person
53
217
2016
71
2,016
74
25
7
33
RRS
23
1,086
71
63
74
17%
60
57
ERRS
ICRR
21%
I-13.2.
463
2
56
66
347
1119
132
987
I-13.3.
ICRR2015
ICRR2015
(International Association
for Radiation Research : IARR)
MSD
Meiji Seika
Precision X-Ray, Inc.
1
RI
1/2
Faxitron (Acrobio)
RCA Regional Office
MK
COLUMBIA
UNIVERSITY
CENTER
/
MEDICAL
I-13.4.
I-13.5.
National Institutes of Health (NIH)/National Cancer Institute (NCI)
I-14.1. Message from the Radiation Research Society (RRS)
President, Radiation Research Society
Gayle E. Woloschak, PhD
The Radiation Research Society expresses its sincere appreciation to the organizing committee of the 15th
International Congress of Radiation Research held in Kyoto Japan on May 25-29, 2015 for presenting to the
world an exemplary Congress rich in outstanding scientific research, and yet also affording participants a small
experience in Japanese culture.
This meeting focused on the theme “Radiation Science Shaping the Future of the Earth and Mankind” and
included cutting-edge presentations that covered all ranges of the radiation sciences from clinical research to
physics to radiation protection.
The accident at Tokyo Electric Power Company’s Fukushima Dai-ichi nuclear power plant after the Great
East Japan Earthquake and Tsunami affected the world in large part because of concerns about radiation leakage
and exposure. ICRR2015 provided an ideal platform for summarizing the accident itself, and the subsequent
radiation and societal findings that resulted from studies that were a follow-up to the accident.
Radiation medicine is an interdisciplinary field with significant contributions coming from physics, chemistry,
biology, and medicine disciplines, all of which are recognized as essential by the Radiation Research Society.
The ICRR 2015 emphasized this multi-dimensional character of the field, and highlighted the many new
discoveries that have contributed to medical discoveries in cancer treatment including heavy-ion therapy, proton
therapy and many more. Innovations in Japan and around the world were discussed extensively at the Congress,
and are likely to have impact on the world radiation community for years to come.
Kyoto also proved to be an ideal location for the Congress. The academic treasures of the city were on
display throughout the Congress, and at several of the related satellite meetings, and the cultural environment
and history of the city provided an important and exciting contribution to the positive experiences of the
participants in the Congress. Japan has once again met a very high mark as international hosts.
It is with great pleasure and admiration that Radiation Research Society extends its congratulations and
thanks to Dr Masahiro Hiraoka, President and Dr. Kenji Kamiya, Secretary-General and the entire planning
committee of the 15th International Congress of Radiation Research for organizing an outstanding Congress.
Gayle E. Woloschak, PhD, President
Radiation Research Society
July 15, 2015
I-14.2. Message from the European Society for Radiation Research
(ERRS)
ERRS President 1, ERRS Secretary Treasurer 2, ERRS Past President 3, ERRS Vice
President 4
Wolfgang Dörr 1, Sarah Baatout 2, George Don Jones 3, Lorenzo Manti 4
The 15th International Congress of Radiation Research (ICRR 2015), held in Kyoto, Japan, in May 2015, was
organised under the general theme of “Radiation Science Shaping the Future of the Earth and Mankind”. This
theme is completely in line with the mission and aims of our society, i.e. “To promote radiation research and
distribution of scientific knowledge in all aspects of radiation science”. ERRS highly appreciated the invitation
to participate in the scientific organization of this congress, and welcomed the opportunity to integrate the
annual, society-specific events, such as the young investigator award presentations and the “Bacq and
Alexander” award lecture, into the scientific programme of the congress.
The organisation of the meeting, with regard to both scientific and social aspects, was excellent. Kyoto
International Conference Center provided an optimal environment for scientific sessions as well as social events
such as the Welcome Reception and the Young Investigators Get Together. The Gala Dinner turned out to be a
rather exciting tour through the exotic atmosphere of the Japanese Ninja and Samurai culture of the Edo
historical period. Kyoto, the City of Ten Thousand Shrines, was a wonderful and exquisite place to experience.
Fully in line with the general theme of the congress, the scientific topics were highly interdisciplinary and
covered all aspects of radiation science. Some specific topics, related to the location of ICRR 2015, were
highlighted in particular sessions and lectures, such as the consequences and conclusions from the Fukushima
accident, or recent results concerning induced stem cells.
A deeper appreciation of the most recent scientific results and progress, plus the widespread sharing of data
among members of the various scientific societies like ours will undoubtedly promote a better understanding of
the mechanisms of action of radiation. This will certainly contribute to a safe and optimized use of radiation in
all relevant disciplines, including medicine, which would in turn lead to a better protection of the environment,
as well as to a significant benefit for human health.
With this message, ERRS congratulates the President of ICRR 2015, Prof. Masahiro Hiraoka, the Secretary
General, Prof. Kenji Kamiya, and the entire scientific committee as to the great success of this congress. ERRS
also thanks all the staff involved in the excellent practical organisation and triumph of the meeting.
I-14.3. Message from the European SocieTy for
Radiotherapy & Oncology (ESTRO)
Núria Jornet; Dirk Verellen; Brad Wouters; Daniel Zips; Philip Poortmans*
and the ESTRO Office In Brussels, Europe.
In the framework of our long tradition of friendship and collaboration with JASTRO, ESTRO was pleased to
support the 15th edition of the ICRR. In agreement with Prof. Masahiro Hiraoka, President and Prof. Kenji
Kamiya, Secretary-General of the meeting, ESTRO appointed three members to the scientific committee of the
meeting: Núria Jornet, Brad Wouters and Philip Poortmans, who helped to shape the excellent scientific profile
of the congress, in close collaboration with all the members of the scientific committee chaired by Prof. Kazuo
Sakai and Prof. Yasumasa Nishimura.
International collaboration in the field of radiation research entails many aspects, one of them being radiation
used to treat malignant diseases. The progress made in the specialty of radiation oncology over the last few
decades is overwhelming, in all aspects of clinical, physics and biological fields of research.
From an often-mere additive treatment after surgery or an approach to relieve symptoms due to local or
metastatic incurable tumours, radiation therapy has evolved to a highly effective curative treatment modality,
often used in combination with surgical or systemic treatments. Palliation can be delivered in a very effective
way, often with only 1 up to a little number of fractions. Organ sparing treatment –avoiding the functional, social
and emotional consequences of total removal of an organ or structure- is now available for many patients,
especially for those with breast, head and neck, prostate, anal and some gynaecological cancers. With highly
directed treatments small primary and metastatic tumours in organs such as lungs or liver can be treated as
effectively as surgical removal. The future lies in individualisation of the optimal (most effective and least toxic)
combination of local and systemic treatments for each specific patient and tumour, taking into account the
patients’ specific circumstances as well.
The synergy between the parallel development of intensity-modulated treatment delivery and on-board
image-guidance, paved the way for more efficient treatments and indeed the exploration of challenging dose
fractionations. An even more challenging opportunity is the clinical implementation of adaptive radiation
therapy where the combination of highly conformal dose distributions (using different dose levels to anticipate
tumour heterogeneity) and real-time imaging allows to adapt the original treatment plan to variations in anatomy
(both gradual changes that occur during the course of treatment as well as managing for example respiratory
induced motion during actual dose delivery) and/or tumour response. Equally important is the challenge of
combining radiation therapy with chemotherapy, targeted therapy, or immune therapy in a patient individualised
manner that maximises tumour control while minimising normal tissue toxicity. As such, state-of-the-art
radiation therapy has become a truly individualized and targeted treatment.
Today, thanks to these advances in treatment delivery and the progress made in the field of in dose calculation,
we can make an accurate estimation of the dose received by the different organs and tissues. This, together with
the advances in quantitative imaging for toxicity and tumour control monitoring, puts us in a privileged position
to model and better understand dose-volume effects in tumours as well as in healthy tissue. This illustrates the
continuously progressive bridging between physics, clinical oncology and radiobiology. Multidisciplinary and
international collaboration is key in these developments that require open fora and a fertile soil for integrated
large-scale clinical implementation of these news concepts.
Concluding, we very much support the inclusion of all aspects of radiation oncology as an integral part of the
International Congress of Radiation Research, together with all other scientific, clinical, physics, environmental
and social aspects related to the use of radiation for peaceful goals.
ESTRO also looks forward to further building on the scientific and educational collaboration with JASTRO
and the broader radiation oncology community as well as with the radiation research community. Platforms as
MELODI in which ESTRO is a partner show the importance of joining efforts from clinical and basic research
to better understand the effect of low doses of radiation on human beings.
Kind regards from Núria Jornet; Dirk Verellen; Brad Wouters; Daniel Zips; Philip Poortmans and the ESTRO
Office In Brussels, Europe.
11 August 2015
I-15.1.
58
ICRR
ICRR2015
2015
18
2015
2012
5
2013
58
7
2013
4
12
10
17
13
21
56
ICRR2015
2012
ICRR2015
26
[Attracted to Radiation Biology: From Thorotrast to the Future]
ICRR2015
36
11
300
27
26
“
DNA
ICRR2015, JRRS
”
ICRR
I-15.2.
ICRR2015
JSRC
ICRR2015
JSRC
2
5
26
12:00-13:00 RoomC1
”International Research
Cooperation Network Meeting for Radiation Chemistry”
ICRR2015
SRC
3
5
27
RoomC1
11:10-12:00
5 26
International Research Cooperation
Network Meeting for Radiation Chemistry
,“JSRC Young Scientist Award Ceremony for 15th International Congress of Radiation
Research (ICRR2015)”
JSRC
ICRR2015
“JSRC Young Scientist Award”
10
”Young Investigators Travel Award”
3
2
“Get together for Young Investigators at ICRR2015”
JSRC
5 27
ICRR2015
JSRC Young Scientist Award for
I-15.3.
53
44
53
44
ICRR2015
27
5
25
5
29
ICRR2015
International
Symposium of Tumor Control by Radiation
5
28
Biology for Stereotactic Irradiation
David J.
Brenner (Columbia University)
Chang W. Song University of Minnesota
Eye opener Tumor Microvasculature as Target of
Therapy
David J Carlson Yale University
5R
LQ
David J. Brenner
H. Rodney Withers
2015 2
His contributions to our understanding
of fractionation effects in radiotherapy were “as clear as the nose on my face”.
Carlson
LQ
LQ
Richard N. Kolesnick Memorial Sloan-Kettering Cancer Center
Yoshiyuki Suzuki Fukushima
Medical University
Recent Progress in Targeting Hypoxic Tumor Cells: from Bench to Clinic (
HIF-1
)
HIF-1
HIF-1
HIF-1
Princess Margaret Cancer Center
dependent glucokinase (ADPGK)
Wounters
ADP-
ROS
ER
HBO
HBO
HBO
HBO
PR350
HBO
III
PR350
3
I-15.4.
5~7
21
34
ICRR
“Radiosensitization in
Clinical Oncology”
ICRR
X
KORTUC
Dr. Mati Ur Rehman
39
2016
2017
7
7
15
2
22
23
I-16.
5
25
Welcome Reception
15
10
ICRR
iPS
Welcome reception
Welcome reception
(ICRR2015
(ICRR2015
(ICRR2015
(ICRR2015
(ICRR2015
Marco Durante
(IARR
(JARR
(
(
(
Gayle E Woloschak
Marco Durante
)
)
)
)
)
Wolfgang Dörr
)
)
Philip M.P. Poortmans
)
)
)
(RRS)
(IARR)
(ICRR)
(JARR)
(ERRS)
(JSRC)
(ESTRO)
(ICRR)
(JASTRO)
(JRRS)
I-17.
5
29
14
5
ICRR2015
ICRR2015
Welcome reception,
Gala dinner
Get Together for Young Investigators
RRS(Radiation Research Society)
ICRR2015
Closing Remarks
JRR(Journal of Radiation Research)
JRR Award at ICRR2015
ICRR2015
11
JRR
Pennelope Jeggo ARR(Association for Radiation Research)
ICRR2019
ARR
PR
IARR
Mary Helen Barcellos-Hoff
IARR
ICRR2015
36
ICRR
ICRR2019
I-18.1.
5
26
250
16
1611
1920
Eye Opener
Lecture
250
8
Gayle E. Woloschak
ICRR
ICRR2015
67
Chang W. Song
Congress
I-18.2.
3
5
27
Get
Together for Young Investigators
200
4
ICRR
JARR
20
3
Meet the Experts
14
Jeggo
Culture of Japan
3
ICRR
I-18.3. Gala Dinner
5
28
18
Gala Dinner
Gala Dinner
2014
2015
8
Gala Dinner
3
700
30-40
JARR
Social Program
Gala Dinner
Gala Dinner
I-18.4.
5
26
27
1
16
30
2
(1
25
)
5
1
2

Download Report